GT Biopharma submits IND to FDA for CD33+ leukemia therapy (GTBP) | Seeking Alpha

Retrieved on: 2023-12-04 15:57:55

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma submits IND to FDA for CD33+ leukemia therapy (GTBP) | Seeking Alpha. View article details on hiswai:

Excerpt

GT Biopharma (GTBP) has submitted an Investigational New Drug application to the FDA for GTB-3650 in the treatment of CD33+ leukemia, ...

Article found on: seekingalpha.com